Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Mitochondrial ribosomal proteins are essential for mitochondrial protein synthesis.
• Mutations in mitochondrial genes can lead to severe human diseases.
• The genetic basis for many mitochondrial disorders remains unknown.

Purpose of the Study:

• To identify the genetic cause of hypertrophic cardiomyopathy, psychomotor retardation, and respiratory chain deficiency in a consanguineous family.
• To investigate the functional consequences of identified mutations on mitochondrial function.

Main Methods:

• Exome sequencing was performed on affected individuals and family members.
• Genetic mapping was used to narrow down the chromosomal regions of interest.
• Functional studies in cultured skin fibroblasts were conducted to assess ribosome assembly and mitochondrial translation.

Main Results:

• A novel missense mutation (P317R) and a large-scale deletion in the MRPL3 gene were identified in affected siblings.
• These mutations were found to impair mitochondrial ribosome assembly and cause mitochondrial translation deficiency.
• Abnormal assembly of respiratory chain complexes was observed in patient-derived fibroblasts.

Conclusions:

• The study identified mutations in MRPL3 as a cause of a novel mitochondrial disorder characterized by hypertrophic cardiomyopathy and psychomotor retardation.
• Exome sequencing combined with genetic mapping is an effective strategy for identifying novel genes involved in mitochondrial diseases.
• Defects in mitochondrial translation can lead to complex clinical phenotypes and respiratory chain dysfunction.